In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Approval Delays for J&J/Basilea's Ceftobiprole Shake Partnership

Executive Summary

Basilea has become so frustrated with partner Johnson & Johnson's efforts--or lack thereof--to get anti-infective ceftobiprole past the regulators that it has resorted to arbitration. The biotech had few other options, but probably has most to lose.
Advertisement

Related Content

Actelion Follows Innovation into GP Markets
Actelion Follows Innovation into GP Markets
Telavancin’s “Complete Response” Letter Calls For Pregnancy-Focused REMS
NDA Delays: Blindsided By Site Problems
Co-Promotes: A Marketplace Reality, But Do They Make Sense?
Co-Promotes: A Marketplace Reality, But Do They Make Sense?
Amylin's Leap of Faith

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel